ATE485050T1 - Verwendung von p43 zur förderung der wundheilung - Google Patents

Verwendung von p43 zur förderung der wundheilung

Info

Publication number
ATE485050T1
ATE485050T1 AT03016724T AT03016724T ATE485050T1 AT E485050 T1 ATE485050 T1 AT E485050T1 AT 03016724 T AT03016724 T AT 03016724T AT 03016724 T AT03016724 T AT 03016724T AT E485050 T1 ATE485050 T1 AT E485050T1
Authority
AT
Austria
Prior art keywords
wound healing
polypeptide
promote wound
epithelialization
monocyte
Prior art date
Application number
AT03016724T
Other languages
English (en)
Inventor
Sunghoon Kim
Original Assignee
Atyr Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atyr Pharma Inc filed Critical Atyr Pharma Inc
Application granted granted Critical
Publication of ATE485050T1 publication Critical patent/ATE485050T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Materials For Medical Uses (AREA)
AT03016724T 2002-07-22 2003-07-22 Verwendung von p43 zur förderung der wundheilung ATE485050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0042858A KR100515016B1 (ko) 2002-07-22 2002-07-22 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물

Publications (1)

Publication Number Publication Date
ATE485050T1 true ATE485050T1 (de) 2010-11-15

Family

ID=29997531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03016724T ATE485050T1 (de) 2002-07-22 2003-07-22 Verwendung von p43 zur förderung der wundheilung

Country Status (5)

Country Link
US (4) US7282208B2 (de)
EP (1) EP1384486B1 (de)
KR (1) KR100515016B1 (de)
AT (1) ATE485050T1 (de)
DE (1) DE60334589D1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물
JP2008528577A (ja) * 2005-02-01 2008-07-31 イマジェネ カンパニー リミテッド コラーゲン合成及び／又はｋｇｆ発現の促進方法
US20090305973A1 (en) * 2006-01-23 2009-12-10 Sung-Hoon Kim Novel peptide and use thereof
WO2008007818A1 (en) * 2006-07-13 2008-01-17 Seoul National University Industry Foundation Novel use of aimp1 for controlling glucose level
EP2121739A4 (de) * 2007-02-01 2010-03-10 Imagene Co Ltd Neues polypeptid mit antitumorwirkung
KR101067817B1 (ko) * 2008-10-10 2011-09-27 서울대학교산학협력단 Ａｉｍｐ1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물
EP2403864B1 (de) 2009-02-27 2015-08-12 Atyr Pharma, Inc. Polypeptidstrukturmotive im zusammenhang mit zellsignalisierungsaktivität
AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
KR20130102534A (ko) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
CA2858613A1 (en) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
EP2814514B1 (de) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
JP6521995B2 (ja) 2014-02-20 2019-05-29 ユニヴァーシティー オブ ノートル ダム デュ ラック 選択的マトリックスメタロプロテイナーゼ阻害剤
US10357546B2 (en) 2014-09-19 2019-07-23 University Of Notre Dame Du Lac Acceleration of diabetic wound healing
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US6391311B1 (en) * 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
MXPA01002875A (es) * 1998-11-13 2002-04-08 Los Angeles Childrens Hospital Metodos para facilitar el crecimiento vascular.
AU5114000A (en) * 2000-06-14 2001-12-24 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokinedomain
KR100405919B1 (ko) * 2001-06-05 2003-11-14 주식회사 이매진 ｐ43의 Ｎ-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물

Also Published As

Publication number Publication date
US7282208B2 (en) 2007-10-16
EP1384486B1 (de) 2010-10-20
DE60334589D1 (de) 2010-12-02
US20080064627A1 (en) 2008-03-13
US7572452B2 (en) 2009-08-11
EP1384486A1 (de) 2004-01-28
US20120010141A1 (en) 2012-01-12
KR100515016B1 (ko) 2005-09-15
US7981426B2 (en) 2011-07-19
US20050119175A1 (en) 2005-06-02
US20100041608A1 (en) 2010-02-18
KR20040009048A (ko) 2004-01-31

Similar Documents

Publication Publication Date Title
DE60334589D1 (de) Verwendung von p43 zur Förderung der Wundheilung
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DK2107109T3 (da) Rekombinant vaskulær endotelcelle-vækstfaktor D (VEGF-D)
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
DE69824755D1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE382685T1 (de) Bakteriophagen-lysin
ATE199095T1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
DE68929430D1 (de) Fibronektin bindendes Protein
BR0008785A (pt) Variantes de polipeptìdeo com capacidade aumentada de ligação com a heparina
ATE452969T1 (de) Lipoxygenase-varianten und ihre verwendung
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DK1028744T3 (da) Neuronale anvendelser af BMP-11
DE60228136D1 (de) Cytokin-proteinfamilie
ES2177625T3 (es) Citoquina cc-1 humana circulante.
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE602004023340D1 (de) Onkogen, davon abgeleitetes rekombinantes Protein und dessen Verwendung
DE69433221D1 (de) Neues Chondrozytprotein
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
DE602005018369D1 (de) Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen
DE602007009797D1 (de) Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon
DE602005024974D1 (de) Polypeptid mit einer Delta-5-Fettsäure-Desaturierungsaktivität, für das Polypeptid codierendes Polynukleotid und Verwendung davon.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties